These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31585123)

  • 1. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
    Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
    Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
    Douchi D; Yamamura A; Matsuo J; Melissa Lim YH; Nuttonmanit N; Shimura M; Suda K; Chen S; Pang S; Kohu K; Abe T; Shioi G; Kim G; Shabbir A; Srivastava S; Unno M; Bok-Yan So J; Teh M; Yeoh KG; Chuang LSH; Ito Y
    Gastroenterology; 2021 Dec; 161(6):1907-1923.e26. PubMed ID: 34391772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
    Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
    J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.
    Thiem S; Eissmann MF; Elzer J; Jonas A; Putoczki TL; Poh A; Nguyen P; Preaudet A; Flanagan D; Vincan E; Waring P; Buchert M; Jarnicki A; Ernst M
    Cancer Res; 2016 Apr; 76(8):2277-87. PubMed ID: 26837764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
    Yamasaki J; Hirata Y; Otsuki Y; Suina K; Saito Y; Masuda K; Okazaki S; Ishimoto T; Saya H; Nagano O
    Cancer Sci; 2022 Mar; 113(3):916-925. PubMed ID: 34931404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gastric cancer modelling using organoids.
    Seidlitz T; Merker SR; Rothe A; Zakrzewski F; von Neubeck C; Grützmann K; Sommer U; Schweitzer C; Schölch S; Uhlemann H; Gaebler AM; Werner K; Krause M; Baretton GB; Welsch T; Koo BK; Aust DE; Klink B; Weitz J; Stange DE
    Gut; 2019 Feb; 68(2):207-217. PubMed ID: 29703791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
    Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
    Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.
    Chung WC; Zhou Y; Atfi A; Xu K
    Neoplasia; 2019 Aug; 21(8):810-821. PubMed ID: 31276933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Stem Cells in the Epithelium of the Stomach Corpus and Antrum of Mice.
    Matsuo J; Kimura S; Yamamura A; Koh CP; Hossain MZ; Heng DL; Kohu K; Voon DC; Hiai H; Unno M; So JB; Zhu F; Srivastava S; Teh M; Yeoh KG; Osato M; Ito Y
    Gastroenterology; 2017 Jan; 152(1):218-231.e14. PubMed ID: 27670082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice.
    Li Q; Jia Z; Wang L; Kong X; Li Q; Guo K; Tan D; Le X; Wei D; Huang S; Mishra L; Xie K
    Gastroenterology; 2012 Mar; 142(3):531-42. PubMed ID: 22155367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer.
    Seidlitz T; Schmäche T; Garcίa F; Lee JH; Qin N; Kochall S; Fohgrub J; Pauck D; Rothe A; Koo BK; Weitz J; Remke M; Muñoz J; Stange DE
    EMBO Mol Med; 2022 Oct; 14(10):e15705. PubMed ID: 35993110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
    Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
    Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.
    Park JW; Jang SH; Park DM; Lim NJ; Deng C; Kim DY; Green JE; Kim HK
    Mol Cancer Res; 2014 Aug; 12(8):1088-99. PubMed ID: 24784840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E-cadherin.
    Park JW; Park DM; Choi BK; Kwon BS; Seong JK; Green JE; Kim DY; Kim HK
    Mol Carcinog; 2015 Nov; 54(11):1521-7. PubMed ID: 25307412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
    Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
    Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.